Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
44.32+0.48 (+1.09%)
At close: 04:00PM EDT
44.30 -0.02 (-0.05%)
After hours: 07:43PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Performance Outlook
Previous Close43.84
Open44.36
Bid37.72 x 1000
Ask44.30 x 1100
Day's Range42.83 - 45.07
52 Week Range31.36 - 46.62
Volume964,975
Avg. Volume961,624
Market Cap6.114B
Beta (5Y Monthly)1.24
PE Ratio (TTM)14.78
EPS (TTM)3.00
Earnings DateAug 08, 2022 - Aug 12, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est48.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
69% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HALO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Halozyme Therapeutics, Inc.
    HALO: Raising target price to $57.00HALOZYME THERAPEUTICS INC has an Investment Rating of BUY; a target price of $57.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement